Regencell Bioscience Holdings Limited (RGC)Healthcare | Drug Manufacturers - Specialty & Generic | Causeway Bay, Hong Kong | NasdaqCM
5.50 USD
-0.02
(-0.362%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 5.51 +0.01 (0.147%) ⇧ (Aug. 28, 2026, 7:49 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 5:22 a.m. EDT
The investment case for Regencell is fundamentally broken. The company is hemorrhaging cash with negative operating cash flow and terrible returns on assets and equity. The balance sheet is precarious, with a book value of merely $0.002 per share while the stock trades at $5.30, implying the market values the company at over 2,600 times its tangible book value—a clear sign that the business is not generating real economic value. While the stock price recently surged due to a class-action lawsuit settlement, this is a one-time event that does not fix the underlying operational rot. The recent price action shows weakness, trading well below its 50-day average, and the statistical forecast offers no reliable edge. There is no dividend to provide income, and the options market is pricing in a wait-and-see approach with heavy protection on the downside. This is a speculative shell with no sustainable business model. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.527873 |
| AutoTheta | 1.002829 |
| AutoARIMA | 1.088784 |
| MSTL | 1.095976 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 0.47 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.422 |
| Excess Kurtosis | -0.81 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 31.68 |
| Market Cap | 2,719,688,960 |
| Beta | 1.49 |
| Website | https://www.regencellbioscience.com |
As of Aug. 22, 2026, 5:22 a.m. EDT: Speculators are positioning defensively with heavy put open interest at strikes significantly below the current price (2.5 and 5.0), suggesting a fear of further downside. Conversely, call activity is concentrated at extremely distant strikes (25 and 35), indicating speculative bets on massive rallies rather than realistic near-term gains. The implied volatility is low across the board, reflecting a lack of active trading and uncertainty.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.570428 |
| Address1 | Chinachem Leighton Plaza |
| Address2 | 9th Floor 29 Leighton Road |
| All Time High | 83.6 |
| All Time Low | 0.079737 |
| Ask | 7.06 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 132,160 |
| Average Daily Volume3 Month | 306,211 |
| Average Volume | 306,211 |
| Average Volume10Days | 132,160 |
| Beta | 1.493 |
| Bid | 4.06 |
| Bid Size | 2 |
| Book Value | 0.002 |
| City | Causeway Bay |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Hong Kong |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.5 |
| Current Ratio | 1.415 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 5.6961 |
| Day Low | 5.44 |
| Debt To Equity | 31.68 |
| Earnings Timestamp End | 1,793,217,600 |
| Earnings Timestamp Start | 1,793,217,600 |
| Ebitda | -7,065,837 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -384.628 |
| Enterprise Value | 2,717,718,016 |
| Eps Trailing Twelve Months | -0.01 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 852 2155 0853 |
| Fifty Day Average | 6.3097 |
| Fifty Day Average Change | -0.8097 |
| Fifty Day Average Change Percent | -0.12832622 |
| Fifty Two Week Change Percent | -57.0428 |
| Fifty Two Week High | 69.0 |
| Fifty Two Week High Change | -63.5 |
| Fifty Two Week High Change Percent | -0.9202899 |
| Fifty Two Week Low | 4.51 |
| Fifty Two Week Low Change | 0.9899998 |
| Fifty Two Week Low Change Percent | 0.21951213 |
| Fifty Two Week Range | 4.51 - 69.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,626,442,200,000 |
| Float Shares | 56,282,728 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 10 |
| Fullday Change | -0.02 |
| Fullday Change Percent | -0.362318 |
| Fullday Price | 5.5081 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.88378996 |
| Held Percent Institutions | 0.0028900001 |
| Implied Shares Outstanding | 494,488,909 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ipo Expected Date | 2,021-07-16 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,751,241,600 |
| Last Split Date | 1,750,032,000 |
| Last Split Factor | 38:1 |
| Long Business Summary | Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong. |
| Long Name | Regencell Bioscience Holdings Limited |
| Market | us_market |
| Market Cap | 2,719,688,960 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_695870118 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -7,048,587 |
| Next Fiscal Year End | 1,782,777,600 |
| Non Diluted Market Cap | 2,724,633,883 |
| Open | 5.5 |
| Operating Cashflow | -4,001,275 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 852 2155 0823 |
| Post Market Change | 0.008100033 |
| Post Market Change Percent | 0.14727332 |
| Post Market Price | 5.5081 |
| Post Market Time | 1,787,960,973 |
| Previous Close | 5.52 |
| Price Hint | 2 |
| Price To Book | 2,749.9998 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.415 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.02 |
| Regular Market Change Percent | -0.362318 |
| Regular Market Day High | 5.6961 |
| Regular Market Day Low | 5.44 |
| Regular Market Day Range | 5.44 - 5.6961 |
| Regular Market Open | 5.5 |
| Regular Market Previous Close | 5.52 |
| Regular Market Price | 5.5 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 73,379 |
| Return On Assets | -0.84972 |
| Return On Equity | -1.77664 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 494,488,908 |
| Shares Percent Shares Out | 0.002 |
| Shares Short | 990,338 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 930,076 |
| Short Name | Regencell Bioscience Holdings L |
| Short Percent Of Float | 0.0179 |
| Short Ratio | 4.25 |
| Source Interval | 15 |
| Symbol | RGC |
| Total Cash | 2,357,216 |
| Total Cash Per Share | 0.005 |
| Total Debt | 386,302 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.01 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 20.137276 |
| Two Hundred Day Average Change | -14.637276 |
| Two Hundred Day Average Change Percent | -0.72687465 |
| Type Disp | Equity |
| Volume | 73,379 |
| Website | https://www.regencellbioscience.com |